Zobrazeno 1 - 10
of 2 092
pro vyhledávání: '"immunoglobulin a nephropathy"'
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Immunoglobulin A nephropathy (IgAN) is a complex renal disease with a highly variable clinical course. Identifying reliable prognostic markers is crucial for risk stratification and treatment decisions. This study aimed to underst
Externí odkaz:
https://doaj.org/article/3259fa0ec12b4e7f840678e007fb462e
Autor:
Hyeon Tae Yang, Tae In Park, Yong-Jin Kim, Mee-seon Kim, Sun-Hee Park, Jeong-Hoon Lim, Yoo Na Kang, DongJa Kim, Man-Hoon Han
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Immunoglobulin A nephropathy (IgAN) is the predominant primary glomerulonephritis globally and remains a subject of active research with a focus on understanding its course and prognosis. Although vascular lesions are associated w
Externí odkaz:
https://doaj.org/article/397dd83bac6948e4823554dd5019f309
Publikováno v:
Kidney & Blood Pressure Research, Vol 49, Iss 1, Pp 799-811 (2024)
Introduction: The diagnosis of Fabry disease (FD) with genetic variants of unknown significance (VUSs) is relatively difficult. We explored patients with novel VUS variants and concomitant immunoglobulin A nephropathy (IgAN) to improve the understand
Externí odkaz:
https://doaj.org/article/3948c7a6ee924cb38502a3edcc9059fb
Publikováno v:
Linchuang shenzangbing zazhi, Vol 24, Iss 9, Pp 737-742 (2024)
Objective To explore the correlation between the expression levels of serum Klotho and uromodulin （UMOD） and immunoglobulin A （IgA） nephropathy complicated with hyperuricemia. Methods From January 1, 2018 to January 1, 2022, 97 hospitalized I
Externí odkaz:
https://doaj.org/article/04c3e42e6b7340218b891eb7e8757180
Autor:
Karol Granak, Matej Vnucak, Monika Beliancinova, Patricia Kleinova, Timea Blichova, Margareta Pytliakova, Ivana Dedinska
Publikováno v:
Acta Medica Martiniana, Vol 24, Iss 2, Pp 86-91 (2024)
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulopathy in our adult population and is associated with a high lifetime risk of kidney failure. Recent years have succeeded in describing the pathogenesis of IgAN at the molecular l
Externí odkaz:
https://doaj.org/article/a39c169e7a974df69f741c88f6d47257
Autor:
Mercedes Galloway, John J. Sim, Andrew Slater, Christopher Bray, Daniel Bishev, Patrick Walker
Publikováno v:
Glomerular Diseases, Vol 4, Iss 1, Pp 167-171 (2024)
Introduction: Anticoagulant-related nephropathy (ARN) is an increasingly recognized cause of acute kidney injury (AKI), initially associated with warfarin use. Supratherapeutic warfarin levels were implicated in kidney toxicity. With the widespread a
Externí odkaz:
https://doaj.org/article/66b66c48d8294606aebd89d784f56f56
Publikováno v:
Renal Failure, Vol 46, Iss 1 (2024)
The mechanisms underlying the complex correlation between immunoglobulin A nephropathy (IgAN) and inflammatory bowel disease (IBD) remain unclear. This study aimed to identify the optimal cross-talk genes, potential pathways, and mutual immune-infilt
Externí odkaz:
https://doaj.org/article/d2723c1612214afa8b0eeefec0968d03
Publikováno v:
Indian Journal of Transplantation, Vol 18, Iss 2, Pp 213-216 (2024)
Primary focal segmental glomerulosclerosis (FSGS) recurrence varies between 10% and 60% and is an important predictor of graft survival. Here, we report the case with a combination of recurrence of FSGS, acute cell-mediated rejection, and donor-deriv
Externí odkaz:
https://doaj.org/article/dd7218706d15406695b5d06db62545e5
Autor:
Szu-Ying Ho, Chih-Chin Kao, Che-Mai Chang, Yi-Chien Chou, Wei-Tzu Luo, Wan-Hsuan Chou, I-Lin Tsai, Mai-Szu Wu, Wei-Chiao Chang
Publikováno v:
Biomarker Research, Vol 12, Iss 1, Pp 1-5 (2024)
Abstract Immunoglobulin A nephropathy (IgAN) is an autoimmune disease characterized by abnormal IgA deposition in glomerulus. Current diagnosis of IgAN still depends on renal biopsy, an invasive method that might increase the risk of clinical outcome
Externí odkaz:
https://doaj.org/article/6ec4a453da69488aaf169760a9015384
Autor:
Mariell Rivedal, Yngvar Lunde Haaskjold, Øystein Eikrem, Rune Bjørneklett, Hans Peter Marti, Thomas Knoop
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Despite several clinical trials, the use of corticosteroid therapy for treating immunoglobulin A nephropathy (IgAN) remains controversial. We aimed to describe the use of corticosteroid therapy combined with supportive therapy in
Externí odkaz:
https://doaj.org/article/824b5472344a465098883508634bfa13